Next Article in Journal
Phase 1 Dose Escalation Study of the Allosteric AKT Inhibitor BAY 1125976 in Advanced Solid Cancer—Lack of Association between Activating AKT Mutation and AKT Inhibition-Derived Efficacy
Previous Article in Journal
Crosstalk between SHH and FGFR Signaling Pathways Controls Tissue Invasion in Medulloblastoma
Previous Article in Special Issue
Secondary Somatic Mutations in G-Protein-Related Pathways and Mutation Signatures in Uveal Melanoma
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Uveal Melanoma

IRCCS Ospedale Policlinico San Martino, 15132 Genova, Italy
Cancers 2019, 11(12), 1986; https://doi.org/10.3390/cancers11121986
Submission received: 3 December 2019 / Accepted: 5 December 2019 / Published: 10 December 2019
(This article belongs to the Special Issue Uveal Melanoma)

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Uveal melanoma (UM) is among the best characterized solid tumors [...]

Share and Cite

MDPI and ACS Style

Pfeffer, U. Uveal Melanoma. Cancers 2019, 11, 1986. https://doi.org/10.3390/cancers11121986

AMA Style

Pfeffer U. Uveal Melanoma. Cancers. 2019; 11(12):1986. https://doi.org/10.3390/cancers11121986

Chicago/Turabian Style

Pfeffer, Ulrich. 2019. "Uveal Melanoma" Cancers 11, no. 12: 1986. https://doi.org/10.3390/cancers11121986

APA Style

Pfeffer, U. (2019). Uveal Melanoma. Cancers, 11(12), 1986. https://doi.org/10.3390/cancers11121986

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop